Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Pfizer returns worldwide rights to TNF-alpha-targeted Nanobodies

Nov. 7, 2011

XTL Biopharmaceuticals set to acquire technology being developed for cartilage-related diseases

Nov. 7, 2011

Atlab Pharma and BZL Biologics enter licensing agreement for [177Lu]-J591

Nov. 4, 2011

BMS and Aslan enter agreement for anticancer compound

Nov. 4, 2011

ExonHit extends strategic collaboration with Allergan

Nov. 3, 2011

Furiex acquires exclusive license to develop MuDelta

Nov. 3, 2011

AgonOx and MedImmune join to develop TNF receptor superfamily member 4 agonists

Nov. 3, 2011

MorphoSys and Shionogi extend HuCAL research partnership

Nov. 2, 2011

Takara Bio to develop gene therapy for non-Hodgkin's lymphoma

Nov. 2, 2011

Oxford BioMedica and Mayo Clinic to collaborate on gene therapy for chronic glaucoma

Oct. 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...